×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| APOLLO HOSPITALS ENTERPRISE LT | 55,907.00 | 3,794.00 | 55,269.00 | 25.89 | 90,837 | 69.3 |
| Zydus Lifesciences Limited | 53266 | 10262 | 52691 | 10.18 | 89087 | 19.6 |
| LUPIN LTD. | 58,214.20 | 8,588.60 | 57,677.10 | 18.69 | 86976 | 30.3 |
Apollo Hospitals Enterprises Ltd.,, with Security Code 508869, is a leading player in the Hospital industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,529.6 | 1,715.5 | 1,638.7 | 1,640.8 | 1,688.4 | 1,866.5 | 1,824.3 | 1,894.6 | 1,936.6 | 2,135.4 |
| Expenses | 1,141.4 | 1,262.5 | 1,221.9 | 1,217.6 | 1,270.7 | 1,387.4 | 1,374.0 | 1,444.2 | 1,465.8 | 1,595.1 |
| Operating Profit | 388.3 | 453.1 | 416.9 | 423.2 | 417.7 | 479.1 | 450.3 | 450.4 | 470.8 | 540.3 |
| OPM % | 25.39% | 26.41% | 25.44% | 25.79% | 24.74% | 25.67% | 24.68% | 23.77% | 24.31% | 25.3% |
| Other Income | 10.5 | 42.9 | 55.3 | 42.8 | 17.8 | 64.6 | 51.6 | 46.0 | 27.3 | 120.9 |
| Interest | 59.6 | 58.4 | 60.2 | 60.6 | 60.9 | 59.6 | 60.6 | 68.7 | 63.5 | 65.4 |
| Depreciation | 89.2 | 92.0 | 88.9 | 96.7 | 93.1 | 93.4 | 97.2 | 115.3 | 102.9 | 108.3 |
| Profit before tax | 250.1 | 345.6 | 323.1 | 308.7 | 281.5 | 390.7 | 344.1 | 312.4 | 331.7 | 487.5 |
| Tax % | 33.2% | 19.2% | 24% | 26.5% | 23.9% | 24.5% | 23.6% | 23.6% | 24.1% | 24.2% |
| Net Profit | 333.1 | 279.2 | 245.6 | 226.9 | 214.1 | 294.8 | 262.9 | 238.8 | 251.7 | 369.6 |
| EPS in Rs | 23.17 | 19.42 | 17.08 | 15.78 | 14.89 | 20.5 | 18.28 | 16.61 | 17.51 | 25.71 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,251.1 | 4,263.6 | 4,302.2 | 4,417.8 | 4,846.9 | 4,850.6 | 4,943.9 | 5,085.6 | 5,589.3 | 5,526.9 |
| Expenses | 3,698.9 | 3,779.8 | 3,814.1 | 3,908.8 | 4,219.4 | 4,236.9 | 4,303.4 | 4,410.5 | 4,773.8 | 4,765.4 |
| Operating Profit | 552.2 | 483.8 | 488.2 | 509.0 | 627.5 | 613.7 | 640.5 | 675.1 | 815.5 | 761.5 |
| OPM % | 13% | 11.3% | 11.3% | 11.5% | 12.9% | 12.7% | 13% | 13.3% | 14.6% | 13.8% |
| Other Income | 22.6 | 35.4 | 16.4 | 28.2 | 24.1 | 27.8 | 28.1 | 37.2 | 38.2 | 63.8 |
| Interest | 92.7 | 100.0 | 95.4 | 106.2 | 111.3 | 112.6 | 119.3 | 116.4 | 117.5 | 109.8 |
| Depreciation | 155.0 | 153.4 | 159.1 | 166.9 | 163.4 | 167.0 | 189.7 | 177.4 | 184.5 | 184.6 |
| Profit before tax | 327.1 | 265.8 | 250.0 | 264.1 | 375.0 | 361.9 | 359.6 | 418.5 | 551.7 | 530.9 |
| Tax % | 33.6% | 36% | 43.2% | 36.6% | 34.5% | 30.1% | 30.5% | 27.4% | 29.3% | 29.5% |
| Net Profit | 212.8 | 162.3 | 145.6 | 173.4 | 248.8 | 254.4 | 258.4 | 315.5 | 395.7 | 379.4 |
| EPS in Rs | 14 | 10 | 10 | 11 | 16 | 17 | 17 | 21 | 26 | 25 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | -3% |
| 3 Years: | 16% |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 26% |
| 3 Years: | 108% |
| TTM: | 20% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 29% |
| 3 Years: | 11% |
| 1 Year: | -7% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 15% |
| 3 Years: | 22% |
| TTM: | 15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 34% |
| 3 Years: | 109% |
| TTM: | 66% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 29% |
| 3 Years: | 11% |
| 1 Year: | -7% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|